NCT02705976
Completed
Not Applicable
Prospective Trial of a Validated Algorithm for Warfarin Dosing
ConditionsAnticoagulation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anticoagulation
- Sponsor
- Aalborg University Hospital
- Enrollment
- 211
- Primary Endpoint
- Time in therapeutic range
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The aim of this study is to perform a randomized trial comparing the use of the algorithm, with dosing of warfarin in standard manual dosage clinical practice, in a high quality anticoagulant setting (PSM). This is done for safety concerns and to ensure good performance of the algorithm when used in a clinical setup. The results from the study are expected to increase our knowledge of efficacy by using the algorithm in clinical practice.
Investigators
Peter Brønnum
Postdoc, PhD
Aalborg University Hospital
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Time in therapeutic range
Time Frame: 6 months
The primary study endpoint, TTR, was calculated according to the Rosendaal method
Secondary Outcomes
- Log of the variance growth rate(6 months)
Similar Trials
Suspended
Not Applicable
A Randomized Trial Measuring the Effect of Decision Aids on Patients' Satisfaction, Conflict of Decision-making and Clinical OutcomeTrapeziometacarpal ArthrosisCarpal Tunnel SyndromeCubital Tunnel SyndromeDistal Radius FracturesTrigger FingerNCT01693094Massachusetts General Hospital126
Completed
Not Applicable
Electronic Intervention for HIV Medication AdherenceHIVNCT01291485Oklahoma State University Center for Health Sciences97
Unknown
Not Applicable
Midurethral Synthetic Tape With Tension Control Mechanism Versus Midurethral Free TapeUrinary Stress IncontinenceNCT04101279Moscow State University of Medicine and Dentistry120
Completed
Not Applicable
The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and RevascularizationCoronary Artery DiseaseNCT03702244HeartFlow, Inc.2,103
Withdrawn
Phase 4
Reinforcement Learning for Warfarin DosingClotting DisorderNCT03962400University of Louisville